Home > About H3D > Governance > Executive Committee

Executive Committee

H3D’s executive committee (EXCO) is responsible for the formulation and oversight of H3D strategy, business plans and financial decisions. 

Prof Kelly Chibale

Director of H3D

Kelly Chibale is the Founder and Director of H3D.

Read more.
He is also the founding Director of the South African Medical Research Council Drug Discovery and Development Research Unit at the University of Cape Town (UCT). He is a full Professor of Organic Chemistry at UCT, a Tier 1 South Africa Research Chair in Drug Discovery and a Full Member of the UCT Institute of Infectious Disease & Molecular Medicine. Kelly is a Fellow of UCT, the Royal Society of South Africa and the Royal Society of Chemistry.

Kelly obtained his PhD in Synthetic Organic Chemistry from the University of Cambridge in the UK with Stuart Warren (1989-1992). This was followed by postdoctoral stints at the University of Liverpool in the UK as a British Ramsay Research Fellow with Nick Greeves (1992-94) and at The Scripps Research Institute in the USA as a Wellcome Trust International Prize Research Fellow with K.C. Nicolaou (1994-96). He was a Sandler Sabbatical Fellow at the University of California San Francisco in the USA (2002), a US Fulbright Senior Research Scholar at the University of Pennsylvania School of Medicine in the USA (2008) and a Visiting Professor at Pfizer in the UK (2008).

Hide this content.


Dr Greg Basarab 

Head of DMPK

Greg Basarab has worked in various aspects of antibacterial and antifungal infection research

Read more.

for over 30 years at AstraZeneca and at DuPont before joining the H3D. novel mode-of-action antibacterial drugs. Two projects led to the identification of drug candidates that entered human clinical trials including one currently in Phase II trials for the treatment of gonorrhea. He is the primary inventor of the two clinical candidates and the inventor otherwise of over 30 patent applications, 19 of which have been granted. Earlier in his career, he led projects at in three departments of the DuPont Corporation: Central Research & Development, Biochemicals and Agricultural Products working mostly in the antifungal arena and in automated chemical synthesis. Before that, he received his academic training first from the Pennsylvania State University to earn a B.S. in Chemistry and then from the Massachusetts Institute of Technology working in natural products total synthesis to earn a Ph.D. in Chemistry.

Hide this content.


Dr Susan Winks

Operations and Research Project Manager

Susan Winks obtained her BSc with distinction in Chemistry and Biochemistry from the
Read more.

University of Cape Town in 2004 and later her BSc(Hons) degree in 2005 also from the University of Cape Town. She came top of her class for honours, winning herself the James Mohr Medal. In 2006 she moved to Johannesburg where she studied her PhD at the University of the Witwatersrand under the supervision of Prof. Jo Michael. During the following 4 years Susan worked as a Teaching Assistant and lectured chemistry to undergraduates. At the end of 2009 Susan completed her PhD entitled “Vinylogous Sulfonamides in the Total Synthesis of Indolizidine Alkaloids from Amphibians and Ants”.

In 2010 Susan started working as a research scientist at Ithemba Pharmaceuticals Ptd Ltd, a start-up biotech focused on drug discovery for neglected diseases. In 2011 she was promoted to Principal Scientist and with her increased involvement in managerial activities she decided to pursue a part-time MBA through the Management College of South Africa, which she obtained in 2014. Susan joined H3D as a Research Officer in August 2013 and in 2015 she retired from the lab bench to increase her involvement in project management and operations at H3D.

Hide this content.


Mrs Ayesha Banderker

Finance and Administration Manager | Admin